NIH funding cuts will negatively affect Utah research facilities, weakening Utah’s competitive edge in science and technology ...

The global populating is aging, and approximately 29% of people with diabetes worldwide are aged 65 years and older, ...

Many US adults—especially young adults and women—are unaware they have high blood pressure, diabetes, or high cholesterol, BIDMC study finds.

Adults with chronic kidney disease and type 2 diabetes had slower kidney function decline with a combination of the nonsteroidal mineralocorticoid receptor antagonist finerenone and empagliflozin vs.

The American College of Lifestyle Medicine (ACLM) has published the first clinical practice guideline to put lifestyle ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

Global type 1 diabetes cases are on the rise, especially in low-income countries, highlighting an urgent need for targeted ...

A diabetes drug may soon double as a treatment for liver disease. Dapagliflozin, an SGLT-2 inhibitor typically used for type 2 diabetes, significantly improved liver inflammation and scarring in ...

A large study of older women suggests metformin may increase the chance of living to age 90. Scientists are increasingly ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

Despite incomplete evidence, longevity enthusiasts are experimenting with SGLT2 inhibitors in their quest to live healthier ...